Insider Transactions in Q3 2024 at Relmada Therapeutics, Inc. (RLMD)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2024
|
Maged Shenouda Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
24,120
+21.45%
|
$48,240
$2.95 P/Share
|
|
Sep 11
2024
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
51,407
+11.81%
|
$102,814
$2.99 P/Share
|
|
Sep 10
2024
|
Maged Shenouda Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
21,118
+24.75%
|
$42,236
$2.73 P/Share
|
|
Sep 10
2024
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
33,014
+9.03%
|
$66,028
$2.75 P/Share
|
|
Sep 09
2024
|
Paul Edward Kelly Director |
BUY
Open market or private purchase
|
Direct |
25,000
+10.54%
|
$50,000
$2.59 P/Share
|
|
Sep 09
2024
|
Maged Shenouda Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
8,194
+15.98%
|
$16,388
$2.55 P/Share
|
|
Sep 09
2024
|
Charles J Casamento Director |
BUY
Open market or private purchase
|
Direct |
13,000
+50.0%
|
$26,000
$2.56 P/Share
|
|
Sep 09
2024
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
55,579
+15.65%
|
$111,158
$2.71 P/Share
|